Expression of NAD+ dependent 15-hydroxyprostaglandin dehydrogenase and protection of prostaglandins in human hair follicle

Experimental Dermatology

Volumn 17, Issue 10, 2008, Pages 821-828

  Michelet, Jean François ^a   Colombe, Laurent ^a   Gautier, Brigitte ^a   Gaillard, Olivier ^a   Benech, Florence ^a   Pereira, Rui ^a   Boulle, Christophe ^a   Dalko Csiba, Maria ^a   Rozot, Roger ^a   Neuwels, Michel ^a   Bernard, Bruno Alain ^a  

^a L ORÉAL RECHERCHE   (France)

Author keywords

15 hydroxyprostaglandin dehydrogenase; Hair follicle; Latanoprost; Prostaglandin

Indexed keywords

13,14 DIHYDRO 15 OXOPROSTAGLANDIN F2 ALPHA; 15 HYDROXYPROSTAGLANDIN DEHYDROGENASE; 2,4 THIAZOLIDINEDIONE DERIVATIVE; ENZYME INHIBITOR; NICOTINAMIDE ADENINE DINUCLEOTIDE; PROSTAGLANDIN; PROSTAGLANDIN DERIVATIVE; PROSTAGLANDIN F2 ALPHA; SALAZOSULFAPYRIDINE;

ADULT; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; DRUG EFFICACY; DRUG SCREENING; DRUG STRUCTURE; DRUG TARGETING; ENZYME INACTIVATION; FEMALE; HAIR FOLLICLE; HAIR GROWTH; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; KERATINOCYTE; MELANOCYTE; NUCLEOTIDE SEQUENCE; PROSTAGLANDIN SYNTHESIS INHIBITION; PROTEIN EXPRESSION; STRUCTURE ANALYSIS;

BIOPSY; BLOTTING, WESTERN; CELLS, CULTURED; CLONING, MOLECULAR; ENZYME INHIBITORS; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HAIR FOLLICLE; HUMANS; HYDROXYPROSTAGLANDIN DEHYDROGENASES; KERATINOCYTES; MELANOCYTES; MIDDLE AGED; PROSTAGLANDINS;

EID: 51949118413     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2008.00706.x     Document Type: Article

References (38)

1. Burton J L, Marshall A. Hypertrichosis due to minoxidil. Br J Dermatol 1979: 101: 593-595.
2. Earhart R N, Ball J, Nuss D D, Aeling J L. Minoxidil-induced hypertrichosis: Treatment with calcium thioglycolate depilatory. South Med J 1977: 70: 442-443.
3. Michelet J F, Commo S, Billoni N, Mahe Y F, Bernard B A. Activation of cytoprotective prostaglandin synthase-1 by minoxidil as a possible explanation for its hair growth-stimulating effect. J Invest Dermatol 1997: 108: 205-209.
4. Hollo G. The side effects of the prostaglandin analogues. Expert Opin Drug Saf 2007: 6: 45-52.
5. Netland P A, Landry T, Sullivan E K et al. Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension. Am J Ophthalmol 2001: 132: 472-484.
6. Yamamoto T, Kitazawa Y. Iris-color change developed after topical isopropyl unoprostone treatment. J Glaucoma 1997: 6: 430-432.
7. Johnstone M A. Hypertrichosis and increased pigmentation of eyelashes and adjacent hair in the region of the ipsilateral eyelids of patients treated with unilateral topical latanoprost. Am J Ophthalmol 1997: 124: 544-547.
8. Johnstone M A, Albert D M. Prostaglandin-induced hair growth. Surv Ophthalmol 2002: 47 (Suppl. 1): S185-S202.
9. Sasaki S, Hozumi Y, Kondo S. Influence of prostaglandin F2alpha and its analogues on hair regrowth and follicular melanogenesis in a murine model. Exp Dermatol 2005: 14: 323-328.
10. Porter R M. Mouse models for human hair loss disorders. J Anat 2003: 202: 125-131.
11. Colombe L, Vindrios A, Michelet J F, Bernard B A. Prostaglandin metabolism in human hair follicle. Exp Dermatol 2007: 16: 762-769.
12. Marnett L J, Rowlinson S W, Goodwin D C, Kalgutkar A S, Lanzo C A. Arachidonic acid oxygenation by COX-1 and COX-2. Mechanisms of catalysis and inhibition. J Biol Chem 1999: 274: 22903-22906.
13. Narumiya S, Sugimoto Y, Ushikubi F. Prostanoid receptors: Structures, properties, and functions. Physiol Rev 1999: 79: 1193-1226.
14. Breyer R M, Bagdassarian C K, Myers S A, Breyer M D. Prostanoid receptors: Subtypes and signaling. Annu Rev Pharmacol Toxicol 2001: 41: 661-690.
15. Penning T M, Steckelbroeck S, Bauman D R et al. Aldo-keto reductase (AKR) 1C3: Role in prostate disease and the development of specific inhibitors. Mol Cell Endocrinol 2006: 248: 182-191.
16. Watanabe K, Yoshida R, Shimizu T, Hayaishi O. Enzymatic formation of prostaglandin F2 alpha from prostaglandin H2 and D2. Purification and properties of prostaglandin F synthetase from bovine lung. J Biol Chem 1985: 260: 7035-7041.
17. Komoto J, Yamada T, Watanabe K, Takusagawa F. Crystal structure of human prostaglandin F synthase (AKR1C3). Biochemistry 2004: 43: 2188-2198.
18. Anggard E, Samuelsson B. Smooth muscle stimulating lipids in sheep iris. The identification of prostaglandin F2a. Prostaglandins and related factors 21. Biochem Pharmacol 1964: 13: 281-283.
19. Nomura T, Lu R, Pucci M L, Schuster V L. The two-step model of prostaglandin signal termination: In vitro reconstitution with the prostaglandin transporter and prostaglandin 15 dehydrogenase. Mol Pharmacol 2004: 65: 973-978.
20. Basu S, Stjernschantz J. Delta13-reductase dependent metabolism of prostaglandins in the mammalian brain and eye. Prostaglandins Leukot Essent Fatty Acids 1997: 57: 305-310.
21. Krook M, Marekov L, Jornvall H. Purification and structural characterization of placental NAD(+)-linked 15-hydroxyprostaglandin dehydrogenase. The primary structure reveals the enzyme to belong to the short-chain alcohol dehydrogenase family. Biochemistry 1990: 29: 738-743.
22. Tai H H, Cho H, Tong M, Ding Y. NAD+-linked 15-hydroxyprostaglandin dehydrogenase: Structure and biological functions. Curr Pharm Des 2006: 12: 955-962.
23. Ensor C M, Tai H H. 15-Hydroxyprostaglandin dehydrogenase. J Lipid Mediat Cell Signal 1995: 12: 313-319.
24. Cho H, Huang L, Hamza A, Gao D, Zhan C G, Tai H H. Role of glutamine 148 of human 15-hydroxyprostaglandin dehydrogenase in catalytic oxidation of prostaglandin E2. Bioorg Med Chem 2006: 14: 6486-6491.
25. Hoffmann R. Steroidogenic isoenzymes in human hair and their potential role in androgenetic alopecia. Dermatology 2003: 206: 85-95.
26. Tong M, Tai H H. Synergistic induction of the nicotinamide adenine dinucleotide-linked 15-hydroxyprostaglandin dehydrogenase by an androgen and interleukin-6 or forskolin in human prostate cancer cells. Endocrinology 2004: 145: 2141-2147.
27. Llau M E, Viraben R, Montastruc J L. Drug-induced alopecia: Review of the literature. Therapie 1995: 50: 145-150.
28. Quidville V, Segond N, Lausson S, Frenkian M, Cohen R, Julienne A. 15-Hydroxyprostaglandin-dehydrogenase is involved in anti-proliferative effect of non-steroidal anti-inflammatory drugs COX-1 inhibitors on a human medullary thyroid carcinoma cell line. Prostaglandins Other Lipid Mediat 2006: 81: 14-30.
29. Tai H H, Ensor C M, Tong M, Zhou H, Yan F Prostaglandin catabolizing enzymes. Prostaglandins Other Lipid Mediat 2002: 68-69: 483-493.
30. Pentland A P, Mahoney M G. Keratinocyte prostaglandin synthesis is enhanced by IL-1. J Invest Dermatol 1990: 94: 43-46.
31. Berry C N, Hoult J R S, Phillips J A, Mc Carthy T M, Agback H. Highly potent inhibition of prostaglandin 15-hydroxydehydrogenase in-vitro and of prostaglandin inactivation in perfused lung by the new azobenzene analogue, Ph CL 28A. J Pharm Pharmacol 1985: 37: 622-628.
32. Watanabe K, Fujii Y, Ohkubo H et al. Expression of bovine lung prostaglandin F synthase in Escherichia coli. Biochem Biophys Res Commun 1991: 181: 272-278.
33. Konger R L, Malaviya R, Pentland A P. Growth regulation of primary human keratinocytes by prostaglandin E receptor EP2 and EP3 subtypes. Biochim Biophys Acta 1998: 1401: 221-234.
34. Pentland A P, Needleman P. Modulation of keratinocyte proliferation in vitro by endogenous prostaglandin synthesis. J Clin Invest 1986: 77: 246-251.
35. Lee J L, Mukhtar H, Bickers D R, Kopelovich L, Athar M. Cyclooxygenases in the skin: Pharmacological and toxicological implications. Toxicol Appl Pharmacol 2003: 192: 294-306.
36. Roenigk H H Jr. New topical agents for hair growth. Clin Dermatol 1988: 6: 119-121.
37. Nandy A, Jenatschke S, Hartung B, Milde-Langosch K, Bamberger A M, Gellersen B. Genomic structure and transcriptional regulation of the human NAD+-dependent 15-hydroxyprostaglandin dehydrogenase gene. J Mol Endocrinol 2003: 31: 105-121.
38. Hazra S, Batra R K, Tai H H, Sharma S, Cui X, Dubinett S.M. Pioglitazone and rosiglitazone decrease PGE2 in non-small cell lung cancer cells by upregulating 15-hydroxyprostaglandin dehydrogenase. Mol Pharmacol 2007: 71: 1715-1720.